MX2008001608A - Piperazinas acetilenicas como antagonistas de receptor de glutamato metabotropico. - Google Patents
Piperazinas acetilenicas como antagonistas de receptor de glutamato metabotropico.Info
- Publication number
- MX2008001608A MX2008001608A MX2008001608A MX2008001608A MX2008001608A MX 2008001608 A MX2008001608 A MX 2008001608A MX 2008001608 A MX2008001608 A MX 2008001608A MX 2008001608 A MX2008001608 A MX 2008001608A MX 2008001608 A MX2008001608 A MX 2008001608A
- Authority
- MX
- Mexico
- Prior art keywords
- piperazines
- acetylenic
- receptor antagonists
- glutamate receptor
- metabotropic glutamate
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
- C07D471/04—Ortho-condensed systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/4985—Pyrazines or piperazines ortho- or peri-condensed with heterocyclic ring systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/06—Anti-spasmodics, e.g. drugs for colics, esophagic dyskinesia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/08—Drugs for disorders of the alimentary tract or the digestive system for nausea, cinetosis or vertigo; Antiemetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/14—Prodigestives, e.g. acids, enzymes, appetite stimulants, antidyspeptics, tonics, antiflatulents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/04—Drugs for disorders of the respiratory system for throat disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/06—Antiasthmatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/16—Central respiratory analeptics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P21/00—Drugs for disorders of the muscular or neuromuscular system
- A61P21/04—Drugs for disorders of the muscular or neuromuscular system for myasthenia gravis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/06—Antimigraine agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/08—Antiepileptics; Anticonvulsants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
- A61P25/16—Anti-Parkinson drugs
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/22—Anxiolytics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
- A61P25/32—Alcohol-abuse
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
- A61P25/36—Opioid-abuse
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
- A61P27/06—Antiglaucoma agents or miotics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/16—Otologicals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
- C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
- C07D487/04—Ortho-condensed systems
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Neurology (AREA)
- Biomedical Technology (AREA)
- Neurosurgery (AREA)
- Pulmonology (AREA)
- Pain & Pain Management (AREA)
- Addiction (AREA)
- Psychiatry (AREA)
- Ophthalmology & Optometry (AREA)
- Physical Education & Sports Medicine (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Rheumatology (AREA)
- Hospice & Palliative Care (AREA)
- Psychology (AREA)
- Otolaryngology (AREA)
- Nutrition Science (AREA)
- Vascular Medicine (AREA)
- Heart & Thoracic Surgery (AREA)
- Immunology (AREA)
- Cardiology (AREA)
- Urology & Nephrology (AREA)
- Epidemiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
Abstract
La invencion se refiere a compuestos de la formula I o sus sales o solvatos farmaceuticamente aceptables, en donde: Ar1, A, B, R1, m y n son como se define en la descripcion. La invencion tambien incluye composiciones farmaceuticas y usos de, y procedimientos para hacer los compuestos, asi como metodos de tratamiento medico de trastornos mediados por mGluR5.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US70794405P | 2005-08-15 | 2005-08-15 | |
PCT/US2006/030394 WO2007021575A2 (en) | 2005-08-15 | 2006-08-04 | Acetylenic piperazines as metabotropic glutamate receptor antagonists |
Publications (1)
Publication Number | Publication Date |
---|---|
MX2008001608A true MX2008001608A (es) | 2008-04-14 |
Family
ID=37670907
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
MX2008001608A MX2008001608A (es) | 2005-08-15 | 2006-08-04 | Piperazinas acetilenicas como antagonistas de receptor de glutamato metabotropico. |
Country Status (16)
Country | Link |
---|---|
US (2) | US20070037817A1 (es) |
EP (1) | EP1919915A2 (es) |
JP (1) | JP2009504736A (es) |
KR (1) | KR20080050569A (es) |
CN (1) | CN101248076A (es) |
AR (1) | AR055113A1 (es) |
AU (1) | AU2006280233A1 (es) |
BR (1) | BRPI0614481A2 (es) |
CA (1) | CA2616318A1 (es) |
IL (1) | IL188807A0 (es) |
MX (1) | MX2008001608A (es) |
NO (1) | NO20080669L (es) |
TW (1) | TW200801005A (es) |
UY (1) | UY29733A1 (es) |
WO (1) | WO2007021575A2 (es) |
ZA (1) | ZA200801033B (es) |
Families Citing this family (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
MX2009002684A (es) | 2006-09-11 | 2009-06-05 | Novartis Ag | Derivados de acido nicotinico como moduladores de receptores de glutamato metabotropico. |
NZ584856A (en) * | 2007-10-12 | 2012-12-21 | Novartis Ag | Metabotropic glutamate receptor modulators for the treatment of parkinson's disease |
WO2009047303A2 (en) * | 2007-10-12 | 2009-04-16 | Novartis Ag | Metabotropic glutamate receptor modulators for the treatment of pervasive developmental disorder |
CN102131503A (zh) | 2008-06-30 | 2011-07-20 | 诺瓦提斯公司 | 用于治疗帕金森病的包含mGluR调节剂的组合产品 |
KR20130100906A (ko) | 2010-04-30 | 2013-09-12 | 노파르티스 아게 | 취약 x 증후군 (fxs) 치료에 유용한 예측용 마커 |
WO2013131981A1 (en) | 2012-03-08 | 2013-09-12 | Novartis Ag | Predictive markers useful in the diagnosis and treatment of fragile x syndrome (fxs) |
CA3088288A1 (en) * | 2018-01-26 | 2019-08-01 | Recordati Industria Chimica E Farmaceutica S.P.A | Triazole, imidazole and pyrrole condensed piperazine derivatives and their use as modulators of mglu5 receptors |
Family Cites Families (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6231833B1 (en) * | 1999-08-05 | 2001-05-15 | Pfizer Inc | 2,7-substituted octahydro-1H-pyrido[1,2-A]pyrazine derivatives as ligands for serotonin receptors |
IL124453A0 (en) * | 1995-12-21 | 1998-12-06 | Pfizer | 2,7-substituted octahydro-pyrrolo [1,2-A]pyrazine derivatives |
EP0982030A3 (en) * | 1998-08-17 | 2000-05-10 | Pfizer Products Inc. | 2,7-substituted octahydro-pyrrolo 1,2-a]pyrazine derivatives as 5ht 1a ligands |
AU1542201A (en) * | 1999-11-05 | 2001-05-14 | Nps Allelix Corp. | Compounds having 5-HT6 receptor antagonist activity |
ES2283768T3 (es) * | 2002-06-06 | 2007-11-01 | Novo Nordisk A/S | Hexahidropirrolo(1,2-a)piracinas, octahidropirido(1,2-a)piracinas y decahidropiracino(1,2-a)acepinas sustituidas. |
-
2006
- 2006-08-03 TW TW095128477A patent/TW200801005A/zh unknown
- 2006-08-04 AU AU2006280233A patent/AU2006280233A1/en not_active Abandoned
- 2006-08-04 KR KR1020087003196A patent/KR20080050569A/ko not_active Application Discontinuation
- 2006-08-04 CN CNA2006800284539A patent/CN101248076A/zh active Pending
- 2006-08-04 US US11/498,836 patent/US20070037817A1/en not_active Abandoned
- 2006-08-04 MX MX2008001608A patent/MX2008001608A/es not_active Application Discontinuation
- 2006-08-04 JP JP2008526975A patent/JP2009504736A/ja active Pending
- 2006-08-04 WO PCT/US2006/030394 patent/WO2007021575A2/en active Application Filing
- 2006-08-04 BR BRPI0614481A patent/BRPI0614481A2/pt not_active IP Right Cessation
- 2006-08-04 CA CA002616318A patent/CA2616318A1/en not_active Abandoned
- 2006-08-04 US US11/997,523 patent/US20080194571A1/en not_active Abandoned
- 2006-08-04 EP EP06789373A patent/EP1919915A2/en not_active Withdrawn
- 2006-08-08 AR ARP060103440A patent/AR055113A1/es unknown
- 2006-08-08 UY UY29733A patent/UY29733A1/es not_active Application Discontinuation
-
2008
- 2008-01-16 IL IL188807A patent/IL188807A0/en unknown
- 2008-01-31 ZA ZA200801033A patent/ZA200801033B/xx unknown
- 2008-02-05 NO NO20080669A patent/NO20080669L/no not_active Application Discontinuation
Also Published As
Publication number | Publication date |
---|---|
NO20080669L (no) | 2008-05-15 |
AR055113A1 (es) | 2007-08-08 |
ZA200801033B (en) | 2009-01-28 |
US20070037817A1 (en) | 2007-02-15 |
IL188807A0 (en) | 2008-08-07 |
WO2007021575A3 (en) | 2007-04-05 |
JP2009504736A (ja) | 2009-02-05 |
EP1919915A2 (en) | 2008-05-14 |
KR20080050569A (ko) | 2008-06-09 |
UY29733A1 (es) | 2007-02-28 |
CN101248076A (zh) | 2008-08-20 |
TW200801005A (en) | 2008-01-01 |
US20080194571A1 (en) | 2008-08-14 |
CA2616318A1 (en) | 2007-02-22 |
AU2006280233A1 (en) | 2007-02-22 |
BRPI0614481A2 (pt) | 2017-06-06 |
WO2007021575A2 (en) | 2007-02-22 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
MX2008001606A (es) | Piperazinas substituidas como antagonistas de receptor de glutamato metabotropico. | |
SG146657A1 (en) | Additional heteropolycyclic compounds and their use as metabotropic glutamate receptor antagonists | |
TW200716120A (en) | Pyrazolo-pyrimidine derivatives as mGluR2 antagonists | |
TW200833328A (en) | 2-aza-bicyclo[3.1.0]hexane derivatives | |
MXPA06009475A (es) | Derivados de quinazolina y usos terapeuticos de los mismos. | |
SE0302760D0 (sv) | New compounds | |
TW200630361A (en) | Integrin antagonists useful as anticancer agents | |
MX2008002061A (es) | Derivados de tiazolil piperidina utiles como moduladores del receptor h3. | |
IL189987A0 (en) | Oxadiazolyl pyrazolo-pyrimidines as mglur2 antagonists | |
MY177111A (en) | Substituted amide derivatives and methods of use | |
ATE493386T1 (de) | Trans-3-aza-bicyclo-ä3.1.0ü-hexan-derivate | |
TW200720260A (en) | Prokineticin 1 receptor antagonists | |
HK1120725A1 (en) | Tetrahydro-beta-carbolin-sulfonamide derivatives as 5-ht6ligands | |
TW200716566A (en) | Prokineticin 2 receptor antagonists | |
MX2007006387A (es) | Derivados de piridina 3-substituidos como antagonistas h3. | |
UA92670C2 (ru) | Пиразолиновые соединения и их фармацевтическое применение, композиция на их основе | |
WO2005037798A3 (en) | Amide or thiomide derivatives and their use in the treatment of pain | |
MX2008001608A (es) | Piperazinas acetilenicas como antagonistas de receptor de glutamato metabotropico. | |
MX2007007027A (es) | Derivados piperazinilpiridina como agentes anti-obesidad. | |
TW200626158A (en) | Naphthaline derivatives | |
MY169274A (en) | Fused, tricyclic sulfonamide inhibitors of gamma secretase | |
TW200637817A (en) | 5-aminoindole derivatives | |
TW200732304A (en) | Piperidine derivatives | |
MX2008001607A (es) | Piperazinas biciclicas como antagonistas del receptor de glutamato metabotropico. | |
RS20050892A (en) | Imidazole derivatives as glutamate receptor antagonists |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FA | Abandonment or withdrawal |